A Karnataka government panel on Wednesday approved investment proposals by biotech major Biocon Ltd. and beverages firm Pepsico for setting up their new production facilities in the state.
"The state high level clearance committee has approved Biocon's Rs.1,060-crore proposal to set up a new plant for manufacturing injectable monoclonal antibodies at Jagani near Bengaluru," said an official statement here.
The panel, chaired by state chief minister Siddaramaiah, also cleared the Rs.590-crore proposals of Peposico India Holdings Ltd to set up a bottling and processing plant for its soft drinks and snacks at Nanjanaugud in Mysuru district, about 200km from here.
Biocon's new facility will generate 750 jobs and Pepsico's plant 900 jobs when commissioned.
The panel also approved Rs.561-crore proposal of Manyata Promoters Ltd. to expand its IT park, convention centre and related infrastructure facilities at Thanisandra in the city's northern suburb. The project is estimated to provide jobs for 7,170 people when completed and occupied.
--IANS
fb/tsb
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
